Fernández-Egea E - Search Results

1

Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia.

Sangüesa E, Fernández-Egea E, Concha J, García CB, Ribate MP. Sangüesa E, et al. Among authors: fernandez egea e. Biomedicines. 2024 Mar 7;12(3):597. doi: 10.3390/biomedicines12030597. Biomedicines. 2024. PMID: 38540209 Free PMC article.

2

Parental history of type 2 diabetes in patients with nonaffective psychosis.

Fernandez-Egea E, Miller B, Bernardo M, Donner T, Kirkpatrick B. Fernandez-Egea E, et al. Schizophr Res. 2008 Jan;98(1-3):302-6. doi: 10.1016/j.schres.2007.10.002. Epub 2007 Nov 26. Schizophr Res. 2008. PMID: 18031995 Free PMC article.

3

Psychosis and catatonia as a first presentation of antiphospholipid syndrome.

Cardinal RN, Shah DN, Edwards CJ, Hughes GR, Fernández-Egea E. Cardinal RN, et al. Br J Psychiatry. 2009 Sep;195(3):272. doi: 10.1192/bjp.195.3.272. Br J Psychiatry. 2009. PMID: 19721128 No abstract available.

4

Sleepwalking Associated With Clozapine Treatment: 2 Cases.

Daniels NF, Fernandez-Egea E. Daniels NF, et al. J Clin Psychopharmacol. 2020 May/Jun;40(3):305-306. doi: 10.1097/JCP.0000000000001208. J Clin Psychopharmacol. 2020. PMID: 32332468 No abstract available.

5

Should obesity be a limiting factor for clozapine treatment?

Pons i Villanueva A, Romero A, Goti J, Fernandez-Egea E, Undurraga J, Carne X, Bernardo M. Pons i Villanueva A, et al. Rev Psiquiatr Salud Ment. 2013 Apr-Jun;6(2):75-9. doi: 10.1016/j.rpsm.2012.05.005. Epub 2012 Jul 24. Rev Psiquiatr Salud Ment. 2013. PMID: 23084801 English, Spanish.

6

Testosterone in newly diagnosed, antipsychotic-naive men with nonaffective psychosis: a test of the accelerated aging hypothesis.

Fernandez-Egea E, García-Rizo C, Miller B, Parellada E, Justicia A, Bernardo M, Kirkpatrick B. Fernandez-Egea E, et al. Psychosom Med. 2011 Oct;73(8):643-7. doi: 10.1097/PSY.0b013e318230343f. Epub 2011 Sep 23. Psychosom Med. 2011. PMID: 21949421 Free PMC article.

7

Influence of secondary sources in the Brief Negative Symptom Scale.

Treen D, Savulich G, Mezquida G, García-Portilla MP, Toll A, García-Rizo C, García-Álvarez L, Bergé D, Bobes J, Bernardo M, Fernandez-Egea E, Mané A. Treen D, et al. Schizophr Res. 2019 Feb;204:452-454. doi: 10.1016/j.schres.2018.10.004. Epub 2018 Oct 11. Schizophr Res. 2019. PMID: 30318172 No abstract available.

8

Differences in glucose tolerance between deficit and nondeficit schizophrenia.

Kirkpatrick B, Fernandez-Egea E, Garcia-Rizo C, Bernardo M. Kirkpatrick B, et al. Schizophr Res. 2009 Feb;107(2-3):122-7. doi: 10.1016/j.schres.2008.09.023. Epub 2008 Nov 28. Schizophr Res. 2009. PMID: 19046857 Free PMC article.

9

Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study.

Pintor LP, Valldeoriola F, Fernández-Egea E, Sánchez R, Rami L, Tolosa E, Muñiz A, Martí MJ, Bernardo M. Pintor LP, et al. J ECT. 2012 Jun;28(2):87-91. doi: 10.1097/YCT.0b013e31823c98c0. J ECT. 2012. PMID: 22531200

10

Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study.

Parellada E, Lomeña F, Catafau AM, Bernardo M, Font M, Fernández-Egea E, Pavía J, Gutierrez F. Parellada E, et al. Psychiatry Res. 2004 Jan 15;130(1):79-84. doi: 10.1016/j.pscychresns.2003.05.001. Psychiatry Res. 2004. PMID: 14972370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters